153 related articles for article (PubMed ID: 18379456)
1. [Myasthenic myopathy].
Sanadze AG; Sidnev DV; Galkina OI; Kasatkina LF; Davydova TV; Rudnichenko VA
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(9):11-6. PubMed ID: 18379456
[TBL] [Abstract][Full Text] [Related]
2. [Anti-Titin-antibodies at the patients with myasthenic and non-myasthenic thymoma].
Vetshev PS; Sanadze AG; Sidnev DV; Ippolitov LI; Zhivotov VA; Ablitsov AIu
Khirurgiia (Mosk); 2007; (6):53-6. PubMed ID: 17690667
[TBL] [Abstract][Full Text] [Related]
3. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
4. The significance of titin antibodies in myasthenia gravis--correlation with thymoma and severity of myasthenia gravis.
Chen XJ; Qiao J; Xiao BG; Lu CZ
J Neurol; 2004 Aug; 251(8):1006-11. PubMed ID: 15316806
[TBL] [Abstract][Full Text] [Related]
5. Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.
Baggi F; Andreetta F; Antozzi C; Simoncini O; Confalonieri P; Labeit S; Cornelio F; Mantegazza R
Ann N Y Acad Sci; 1998 May; 841():538-41. PubMed ID: 9668290
[No Abstract] [Full Text] [Related]
6. Paraneoplastic myasthenia gravis: immunological and clinical aspects.
Skeie GO; Romi F
Eur J Neurol; 2008 Oct; 15(10):1029-33. PubMed ID: 18717725
[TBL] [Abstract][Full Text] [Related]
7. The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies.
Romi F; Skeie GO; Aarli JA; Gilhus NE
Arch Neurol; 2000 Nov; 57(11):1596-600. PubMed ID: 11074791
[TBL] [Abstract][Full Text] [Related]
8. Titin and ryanodine receptor autoantibodies in dogs with thymoma and late-onset myasthenia gravis.
Shelton GD; Skeie GO; Kass PH; Aarli JA
Vet Immunol Immunopathol; 2001 Jan; 78(1):97-105. PubMed ID: 11182151
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
10. Striational autoantibodies in myasthenia gravis patients recognize I-band titin epitopes.
Lübke E; Freiburg A; Skeie GO; Kolmerer B; Labeit S; Aarli JA; Gilhus NE; Wollmann R; Wussling M; Rüegg JC; Linke WA
J Neuroimmunol; 1998 Jan; 81(1-2):98-108. PubMed ID: 9521611
[TBL] [Abstract][Full Text] [Related]
11. Thymectomy and antimuscle antibodies in nonthymomatous myasthenia gravis.
Romi F; Gilhus NE; Varhaug JE; Myking A; Skeie GO; Aarli JA
Ann N Y Acad Sci; 2003 Sep; 998():481-90. PubMed ID: 14592917
[TBL] [Abstract][Full Text] [Related]
12. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin.
Gautel M; Lakey A; Barlow DP; Holmes Z; Scales S; Leonard K; Labeit S; Mygland A; Gilhus NE; Aarli JA
Neurology; 1993 Aug; 43(8):1581-5. PubMed ID: 8351016
[TBL] [Abstract][Full Text] [Related]
13. Myasthenia gravis in individuals over 40.
Aarli JA; Romi F; Skeie GO; Gilhus NE
Ann N Y Acad Sci; 2003 Sep; 998():424-31. PubMed ID: 14592910
[TBL] [Abstract][Full Text] [Related]
14. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients.
Yamamoto AM; Gajdos P; Eymard B; Tranchant C; Warter JM; Gomez L; Bourquin C; Bach JF; Garchon HJ
Arch Neurol; 2001 Jun; 58(6):885-90. PubMed ID: 11405802
[TBL] [Abstract][Full Text] [Related]
15. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Buckley C; Newsom-Davis J; Willcox N; Vincent A
Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
[TBL] [Abstract][Full Text] [Related]
16. Anti-titin antibodies are not associated with a specific thymoma histology.
Voltz R; Albrich W; Hohlfeld R; Nagel D; Wick M; Kirchner T; Sommer N; Illa I; Kaminski H; Schumm F
J Neurol Neurosurg Psychiatry; 2003 Feb; 74(2):282. PubMed ID: 12531976
[No Abstract] [Full Text] [Related]
17. Titin, thymoma, and myasthenia gravis.
Aarli JA
Arch Neurol; 2001 Jun; 58(6):869-70. PubMed ID: 11405799
[No Abstract] [Full Text] [Related]
18. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
19. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis.
Mygland A; Aarli JA; Matre R; Gilhus NE
J Neurol Neurosurg Psychiatry; 1994 Jul; 57(7):843-6. PubMed ID: 8021674
[TBL] [Abstract][Full Text] [Related]
20. Titin and ryanodine receptor epitopes are expressed in cortical thymoma along with costimulatory molecules.
Romi F; Bø L; Skeie GO; Myking A; Aarli JA; Gilhus NE
J Neuroimmunol; 2002 Jul; 128(1-2):82-9. PubMed ID: 12098514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
